Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Nov 1, 2017 | Tricida | $58.0M Series D | — | Atlas Venture, OrbiMed, Cormorant Asset Management, Longitude Capital, Sibling Capital Ventures, Venrock, Vivo Capital, Wellington Management |
| Jul 1, 2016 | Tricida | $55.0M Series C | David Hirsch | Atlas Venture, OrbiMed, Sibling Capital Ventures, Vivo Capital |
| Jul 23, 2015 | Ra Pharmaceuticals | $58.5M Series B | Lightstone Ventures, Novo Ventures, Rajeev Shah | Amgen Ventures, Morgenthaler Ventures, New Enterprise Associates, Novartis, Rock Springs Capital |
| Mar 1, 2015 | Tricida | $30.0M Series B | OrbiMed | Atlas Venture, Sandra Coufal |